24th May 2016 08:32
LONDON (Alliance News) - Hikma Pharmaceuticals PLC Tuesday said Chief Financial Officer Khalid Nabilsi sold 20,000 shares at a price of 2,285 pence per share on Monday.
Following this transaction, Nabilsi now holds 201,921 shares, which equals a 0.08% stake in the Jordan-founded drug maker.
The stock was down 0.2% at 2,277.00p Tuesday.
By Arvind Bhunjun; [email protected]; @ArvindBhunjun
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
Hikma Pharmaceuticals